UnknownNot applicableNCT04223674

Serological Screen and Treat Trial for Plasmodium Vivax

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Indonesia University
Principal Investigator
Inge Sutanto, MD, PhD
Indonesia University
Intervention
Serological screen and treat(diagnostic_test)
Enrollment
1133 target
Eligibility
6-15 years · All sexes
Timeline
2022 – 2023

Study locations (1)

Collaborators

Eijkman Institute for Molecular Biology · Oxford University Clinical Research Unit Indonesia · Walter and Eliza Hall Institute of Medical Research · Rumah Sakit Umum Daerah Mimika · Universitas Sumatera Utara

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04223674 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials